Seroprevalence of anti-HCV among HIV-infected persons and general population

J Med Assoc Thai. 1995 Nov;78(11):611-7.

Abstract

From November 1993 to December 1994, the seroprevalence of anti-HCV, HBsAg was studied among 346 HIV-infected persons (asymptomatic HIV-infected persons and AIDS patients) and 1,023 subjects from the general population (including 119 cord blood samples). The prevalence of anti-HCV, HBsAg among HIV-infected patients aged 15-45+ years was 11.0 and 11.6 per cent respectively which is significantly higher than the comparable levels for the general population (1.9% and 4.7%) in the age group 15-44 years. There was no statistically significant association of anti-HCV and HBsAg prevalence among 200 asymptomatic HIV-infected carriers and 146 AIDS patients. Assays for anti-HCV among blood donors are highly recommended to reduce the development of liver disease or cirrhosis in the immediate future.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Chi-Square Distribution
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HIV Infections / complications*
  • HIV Infections / immunology
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis C / complications*
  • Hepatitis C / epidemiology*
  • Hepatitis C / immunology
  • Hepatitis C Antibodies / analysis*
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Seroepidemiologic Studies
  • Sex Distribution

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies